Previous 10 | Next 10 |
NEW YORK and WALTHAM, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Minerva Neurosciences, Inc. (Nasdaq: NERV) today announced that Royalty Pharma will acquire Minerva’s royalty interest in seltorexant for an upfront payment of $60 million and up to $...
WALTHAM, Mass. and NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Royalty Pharma will acquire Minerva’s royalty interest in seltorexant for an upfront payment of $60 million and up to $...
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of SPLK, NAK, and NERV. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead pl...
NERV had a chat with the FDA, the market didn't like the details. The phase 3 study might actually have succeeded, based on a modified intent-to-treat analysis. NERV is planning to run a bioequivalence study, adding a catalyst to the calendar. For further details see: A ...
Gainers: Auris Medical (EARS) +360%.BlackBerry (BB) +53%.Corporacion America Airports (CAAP) +41%.Onconova Therapeutics (ONTX) +36%.Jaguar Health (JAGX) +29%.Xunlei (XNET) +29%.Codiak BioSciences (CDAK) +27%.Arlo Technologies (ARLO) +27%.F-star Therapeutics (FSTX) +21%.ReWalk Roboti...
Gainers: Auris Medical Holding (EARS) +213%. Jaguar Health (JAGX) +56%. F-star Therapeutics (FSTX) +34%. Zomedica (ZOM) +24%. Codiak BioSciences (CDAK) +16%.Losers: Minerva Neurosciences (NERV) -23%. Titan Pharmaceuticals (TTNP) -23%. Cocrystal Pharma (COCP) -22%. Apollo Endosurgery (APEN) -1...
Minerva Neurosciences (NERV) slumps 15% premarket on increased volume in reaction to its receipt of minutes from a recent meeting with the FDA regarding the data package supporting its planned marketing application seeking approval of roluperidone for the treatment of negative sympt...
Titan Pharmaceuticals (TTNP) -15%.Tuniu TOUR -15% on Q3 earnings release.Medigus MDGS -15% on appointment of new finance chief at MedigusECMOHO MOHO -14% on Q3 earnings release.Minerva Neurosciences (NERV) -14% after announcing outcome of Type C meeting with...
WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it has received official meeting minutes fro...
WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will participate in the Jeffer...
News, Short Squeeze, Breakout and More Instantly...
Minerva Neurosciences Inc Company Name:
NERV Stock Symbol:
NASDAQ Market:
Minerva Neurosciences Inc Website:
BURLINGTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported business updates and financial results for the first q...
A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 19.3% to $6.86 on volume of 301,330,136 shares Canoo Inc. (GOEV) rose 8.3% to $0.1138 on volume of 118,801,751 shares Ault Alliance Inc. (AULT) rose 19.1% to $0.4642 on volume of 117,184,555 shares Mar...